During neonatal development glucocorticoids potentiate oligodendrocyte differentiation and myelinogenesis by regulating the expes of myelin basic protein, proteolipid protein, and glycerol phosphate dehydrogenase (snglycerol-3-phosphate: NAD' 2-oxidoreductase, EC 1.1.1.8).
The actual locus at which hydrocortisone exerts its developmental influence on glal physiology is, however, not well understood. Gycerol phosphate dehydrogenase is glucocorticoid-inducible in oligodendrocytes at all stages of development both in vivo and in vitro. In newborn rat cerebral cultures, between 9 and 15 days in vitro, a 2-to 3-fold increase in myelin basic protein and proteolipid protein mRNA levels occurs in oligodendrocytes within 12 hr of hydrocortisone treatment. Immunotaining demonstrates that this increase in mRNAs is followed by a 2-to 3-fold increase in the protein levels within 24 hr. In vitro transcription assays performed with oligodendrocyte nuclei show an 11-fold increase in the transcriptional activity of glycerol phosphate dehydrogenase in response to hydrocortisone but no increase in transcription of myelin basic protein or proteolipid protein. These results indicate that during early myelinogenesis, glucocorticoids influence the expression of key oligodendroglial markers by different processes: The expression of glycerol phosphate dehydrogenase is regulated at the transcriptional level, whereas the expression of myelin basic protein and proteolipid protein is modulated via a different, yet uncharacterized, mechanism involving posttranscriptional regulation.
The expression of glycerol phosphate dehydrogenase (GPDH; sn-glycerol-3-phosphate: NAD' 2-oxidoreductase, EC 1.1.1.8), myelin basic protein (MBP) , and proteolipid protein (PLP) marks the differentiation of oligodendrocytes, the myelinating cells in the central nervous system (1, 2) . MBP and PLP are components of the myelin sheath, constituting 30%o and 50%o of the proteins in myelin, respectively. The expression and biosynthesis of MBP and PLP in oligodendrocytes have been shown to be coordinately expressed with the process of myelination (3) (4) (5) (6) .
Peak expression of GPDH during neonatal development also coincides with the active period of myelination (7, 8) . Localized in oligodendrocytes (9) , GPDH provides glycerol phosphate for the biosynthesis of phosphatides (10), a precursor for membrane components (11) . The developmental regulation of GPDH gene expression and its modulation by glucocorticoids in the rat brain and in primary cultures of oligodendrocytes have been well characterized (12) .
Glucocorticoids and other hormones have been implicated in the stimulation of myelinogenesis (13) (14) (15) (16) . During glial differentiation, the expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase) has been shown to be increased by dexamethasone, a potent glucocorticoid agonist, both in reaggregating (13) and dissociated (14) (16) .
The ability ofglucocorticoids to influence the developmental expression of genes in the brain correlates highly with the ontogeny of glucocorticoid receptor in target cells. A developmental rise in the levels of unoccupied glucocorticoid receptor and nuclear acceptor site (or nuclear binding sites) has been seen in the rat brain during the first week of life, reaching its maximum during the second week of development (17, 18) . Primary cultures of rat oligodendrocytes and astrocytes have abundant levels of glucocorticoid receptors (12) . /
In this study, we show that like GPDH, MBP and PLP are also glucocorticoid-inducible in oligodendrocytes during development . In contrast to GPDH, which is transcriptionally regulated throughout the age of the culture, the glucocorticoid induction ofMBP and PLP is developmentally restricted and involves post-transcriptional regulation during the second postnatal week, the period of myelinogenesis in the rat cerebrum.
METHODS
Cell Culture Preparation. Primary glial cell cultures were prepared from cerebral cortices of 1-to 2-day postnatal Wistar rats as described (19) . Secondary cultures of astrocytes and oligodendrocytes were prepared by mechanically shaking 7-to 9-day-old confluent primary glial cultures, essentially as described by McCarthy and de Vellis (20) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
except that the cultures were shaken for 6 hr to remove macrophages before the 18-hr shake, which yields oligodendrocytes.
Immununocytochemistry. The rabbit antibody to GPDH has been described (21); the rabbit anti-MBP was from L Bologa (Zurich); and the rabbit anti-PLP was generated by the method of Vaitukaitis (22) from a purified rat brain PLP preparation. For immunostaining, cultures were fixed and treated with primary antibodies at 1:50 dilutions by a described method (23) . A 1:200 dilution of goat anti-rabbit IgG was used as a second antibody, followed by peroxidaseantiperoxidase treatment (24) .
Preparation In Vito Transcription Assays. The run-off transcription of MBP, PLP, and GPDH from cultured cells followed the described method (8, 30) .
RESULTS
Primary cell cultures prepared from neonatal rat cerebral cortex consist of a bedlayer of astrocytes overlaid by phasedark process-bearing cells that mature into oligodendrocytes (20) . Immunostaining of these cultures demonstrates that some process-bearing cells lying on top of an astrocyte bedlayer express the oligodendrocyte marked GPDH (Fig.  LA) . The treatment of the cultures with hydrocortisone for 24 or 48 hr considerably increased the expression of GPDH antigen ( Fig. 1 B and C ). For example, the level of expression of GPDH in 8-day-old mixed glia treated with hydrocortisone for 48 hr resembles levels found in 2-to 3-week-old cultures. For comparison, the immunostaining of GPDH in an 18-day-old culture not treated with hydrocortisone is shown (Fig. 1D) . To more closely compare the basal and induced levels of GPDH, the total numbers of process-bearing cells and GPDH-positive cells were counted at various times over a 4-week period. The total number of process-bearing cells in either the control or glucocorticoid-treated cultures was the same at each corresponding age. Fig. 2 shows that the percent of GPDH-positive cells increases several-fold in response to hydrocortisone throughout the culture time.
Immunostaining shows MBP and PLP to be primarily membrane-bound, forming a halo around the cell boundary (Fig. 3) , in contrast to GPDH, which is uniformly distributed (Fig. 1) . Because immunostains in vivo show that MBP and PLP appear relatively late in development, a striking result has been the precocious expression of both MBP and PLP in in vitro hydrocortisone-treated phase-dark cells (Fig. 3 B, C, E, and F) . This increase in MBP and PLP antigens in oligodendrocytes in response to hydrocortisone is evident only in early cultures, ranging between day 9 and day 15 . No significant glucocorticoid-mediated induction of immunodetectable MBP and PLP was evident (n the cultures before day 9 (data not shown). In hydrocortisone-treated older cultures, both the MBP-and PLP-positive cells appeared in large clusters, making single-cell evaluation more difficult. Once again, in hydrocortisone-treated cultures, the percent of MBP-or PLP-positive process-bearing cells increased, although not as much as seen for GPDH (Fig. 2) .
The hormonally regulated developmental expression of MBP and PLP was also analyzed by Northern (RNA) blot (Fig. 4) 12 hr (Fig. 5) . No detectable levels of MBP, PLP, and GPDH were seen in astrocytes. The glucocorticoid-mediated increases of MBP and PLP mRNAs were much less than the Proc. Natl. Acad. Sci. USA 86 (1989) 6809 glucocorticoid-mediated increase in GPDH mRNA. Previously, we demonstrated that the glucocorticoid-mediated induction of GPDH mRNA in these cells is transcriptionally regulated by using in vitro run-off transcription assays in nuclei isolated from C6 cells (8) . To examine the mechanism of action of hydrocortisone on oligodendroglial markers in process-bearing cells, we performed in vitro transcription assays with nuclei isolated from cultures of oligodendrocytes either untreated or treated with hydrocortisone for 12 hr. The 32P-labeled transcribed heterogeneous nuclear RNAs were hybridized to nitrocellulose discs containing GPDH, MBP, or PLP clone cDNAs. As is clear from Fig. 6 , glucocorticoids do not increase the transcription of MBP and PLP mRNAs over their untreated levels, whereas an 11-fold increase in the GPDH gene activity was seen in response to hydrocortisone.
DISCUSSION
We have begun to characterize a glial culture system for the study of hormonal regulation of developmental expression of oligodendroglial-specific marker genes. Prepared from the cerebral cortices of 1-to 2-day postnatal rat pups, mixed glial cultures can be maintained for weeks and examined for developmental expression of different markers, both at basal levels and in response to hormones. In a 7-to 9-day-old culture, the oligodendrocytes appear as phase-dark processbearing cells overlaying a confluent bedlayer of phase-light astrocytes (20) . These process-bearing cells have been previously characterized by ultrastructural, immunocytochemical, biochemical, and molecular criteria (19, 23, 31) . The enriched population of process-bearing cells shaken off the astrocyte bedlayer is primarily constituted of oligodendrocytes and exhibits very few glial fibrillary acidic proteinpositive cells (31) . From the present study and others (19, 23) broside, CNPase (31), transferrin (23) , and MBP (19, 32) , has been reported in cultures ofphase-dark process-bearing cells; however, these markers are not always co-localized within the same cell (19, 23 Therefore, this hormonal effect on MBP expression is a developmentally restricted phenomenon and differs from GPDH induction, which is inducible throughout the life-span of the animal and cell culture (12) .
We have shown earlier that GPDH is transcriptionally regulated by glucocorticoids in C6, a transformed glial cell line (8) . The 
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cation of current molecular techniques and the future investigation of hormonal control of glial development.
